SYNOPSIS Among 24 male blood donors without anaemia who had been giving a mean of 2-2 donations per year involving a mean blood loss of about 900 ml a year, 10 (41 %) were found to be depleted of storage iron. This is somewhat higher but similar to the previously recorded findings in healthy women without anaemia.
SYNOPSIS Among 24 male blood donors without anaemia who had been giving a mean of 2-2 donations per year involving a mean blood loss of about 900 ml a year, 10 (41 %) were found to be depleted of storage iron. This is somewhat higher but similar to the previously recorded findings in healthy women without anaemia.
The results may well support a policy of limiting blood donation to twice a year in men and to once a year in women. Both men and women blood donors require medicinal iron after each donation.
It is considered that storage iron depletion in non-anaemic women is not in the main related to pathological levels of menstrual loss but rather to inadequate dietary iron. Food iron in present-day diets should be supplemented.
In a previous study (Fielding, O'Shaughnessy, and Brunstrom, 1965) it was shown that there was less storage iron, measured as desferrioxamine chelatable iron, in healthy women than in healthy men. In as many as a third of normal women without anaemia, i.e. with haemoglobin concentration above 120 g per 100 ml, storage iron was in the same range as in severe iron-deficiency anaemia, in which it is known with certainty that storage iron is depleted. As in the well known mild chronic anaemia which afflicts numerous women, the most likely explanation of this finding is the effect of menstrual loss on iron status. It has been shown by direct measurement (Frenchman and Johnson, 1949; Hallberg, Hogdahl, Nilsson, and Rybo, 1966) 
METHODS
Desferrioxamine chelatable iron was measured by the differential ferrioxamine test (Fielding, 1965) . The procedure consists of an intravenous injection of a bodyweight dose of desferrioxamine methanesulphonate (Desferal, Ciba) together with a body-weight dose of ferrioxamine labelled with 2,uC59Fe. A six-hour specimen of urine is collected. The amount of injected ferrioxamine excreted is estimated as 59Fe by standard methods and the total amount of ferrioxamine excreted is estimated chemically. The difference between the two estimations gives the amount of ferrioxamine which has been derived from chelation of storage iron in vivo; the amount of ferrioxamine formed from body iron (Fv) is calculated by simple proportion and expressed in micrograms ferrioxamine hydrochloride per kilogram body weight.
Serum iron was determined by the method of Kok and Wild (1960) and total serum iron-binding capacity (TIBC) by the adsorption of excess ferric chloride with magnesium carbonate (Ramsay, 1957 (Table II) . (Weinfeld, 1964; Mollison, 1967) . The present results show that in 10 out of 24 male donors without anaemia, storage iron was depleted to the same extent as found in patients with severe iron-deficiency anaemia. Although these donors had no anaemia, in some instances a low serum iron level was found and more frequently a high serum iron-binding capacity.
The donors who suffered storage iron depletion had given blood for a mean of 15-9 years with a mean of 2-3 donations a year. Those with storage iron in the normal range had as a group been donors for a somewhat shorter period, with a mean of 14-8 years, and had donated blood slightly less frequently with a mean of 2-0 donations a year. The differences in frequency are not large but they amount to a mean difference of about 1,000 mg iron loss between the two groups during their donor experience. A detailed dietary history revealed no differences in dietary iron in the two groups. It remains possible that the smaller group of donors with depleted storage iron are those whose capacity to augment intestinal iron absorbed from iron in food after blood loss is not as great as in the larger group.
These figures support a policy of restricting blood donation from men to twice a year, that is to a blood loss of about 900 ml. It should be recognized that a corollary of such a policy is to limit blood donation from women to once a year since they already experience a mean physiological loss of about 500 ml per year. It would appear important to offer medicinal iron to both men and women blood donors after each donation; to what extent this would permit more frequent donation is not known.
A mean loss of 2-3 transfusion units of blood in male donors with storage iron depletion is the equivalent of about 960 ml blood loss per year, while a mean loss of 2-1 units among those with normal storage iron is the equivalent of about 880 ml per year. Blood loss in these circumstances is not of course quite comparable with losses in menstruating women, since it is incurred at less frequent intervals, but it is nevertheless arithmetically equivalent to menstrual loss of about 80 ml and 70 ml per cycle respectively. Our results have shown that healthy men with blood losses of this order have among them about 40% with depleted storage iron. The proportion of apparently healthy women without anaemiawho were found to be depleted of iron by the same test is 30 %: it is highly probable, therefore, that these iron-depleted women without anaemia were not as a group experiencing blood losses of more than 70 to 80 ml per cycle. This conclusion supports the observations of Hallberg et al (1966) who found no change in the mean haemoglobin concentration of women in Goteborg with menstrual losses of up to 100 ml per cycle, but there was a perceptible trend to low serum iron values and high TIBC when losses rose above 60 ml per cycle.
It is obvious that iron status in women depends not only on blood loss but on the amount of food iron and intestinal absorption. It may be reasonable to consider losses of over 100 ml per cycle as pathological, since this appears to be invariably accompanied by anaemia. It is, however, equally unreasonable to consider as pathological smaller losses in women who complain of no inconvenience and on investigation show no gynaecological or other pathology. Yet 30% of such apparently normal women without anaemia are found to be depleted of storage iron. In this situation a change of emphasis is needed from the role of menstrual loss to the role of inadequate iron intake.
It seems that the amount of iron which can be absorbed from a modem diet is inadequate to provide normal iron stores for about a third of 
